Clinical Trial Update: Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating strategies to sustain control of cardiac risk factors after discharge from a cardiovascular risk reduction program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus
• Dyslipidemia
• Hypertension

Snippet

Sponsor: Providence VA Medical Center | Conditions: Diabetes, Dyslipidemia | Phase 3 | Status: COMPLETED